13 September, 2017
The total number of shares traded in the last 90-day period is 0. The company's market cap is $7.16 Million.
Penny stocks are low-cost, making them attractive to investors who may not have the capital to purchase the more expensive blue-chip shares from large companies.
On a similar note, analysts expect EPS of $1.69 in September 2017 quarter and $1.7 in December 2017 quarter, representing 6.96% and -0.58% growth, respectively.
The most recent open market insider trade was Buy of 2,500 shares on a day where the closing price was 0.63. PPHM price is down almost -78.95% from its 52-week high price of $5.78 a share but is up about 39.01% from its 52-week low price of $1.97 a share. The results of the trading session contributed to over 13,990,047 shares changing hands. Unusual volume shows something has likely happened in the stock-such as a news release or traders have become anxious or euphoric about the stock's potential. Atossa Genetics Inc. (ATOS) now trades with a market capitalization of $9.36 Million. The stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 0. Considering the latest volume move the stock can be referred as "Hot" and "Eye-catching". In the same way a stock's beta shows its relation to market shifts, it is also an indicator for required returns on investment (ROI). The PEG ratio is used to determine a stock's value while taking the company's earnings growth into account, and is considered to provide a more complete picture than the P/E ratio. For the most recent quarter, quick ratio was 0, current ratio was 2.1, LT Debt/Equity ratio was 0 and Total Debt/Equity ratio stands at 0, while Payout ratio is 0. "Initiates Coverage on" Atossa Genetics Inc (NASDAQ:ATOS) to Buy and on 3/20/13 Dawson James "Downgrades" the stock to Buy at $16. Analysts, on average, seem bullish as they suggest ATOS is worth $25.65 more, giving a target price of $26.25 a share. (ATOS) stock price comparison to its moving averages, shares of company are 44.94% away from the 50-day moving average and 41.24% away from 20-day average. The analysts estimated EPS for the higher end at -2.11 and lower end at -2.11 while the year ago reported earnings per share was -5.24.
EPS Estimate for the next Quarter is 0. The percentage of shares being held by the company management was 0% while institutional stake was 8%.
Annual EPS growth Past 5 years is 17.5 percent. That represents an overall change in revenues, on a quarterly year/year basis, of0%. A low ROE warns that the company is not generating a good return on its reinvested earnings. In the past 3-month period alone, shares of ATOS have appreciated +0.06 - or +11.11%. The Volatility was noted at 1.50% in recent month and it observed Weekly Volatility of 1.36%. The total number of shares traded in the last 12 months is 2,500. EPS long term mean growth rate estimated by analysts is at 140.91%, whereas, the high and low Long term growth rate estimated at 33.64.
Atossa Genetics Inc. (ATOS) showed volatility of 12.54% over the past week.